FCGR2A and neoplasm: These chimeric IgG-like bsAbs are actually bispecific and trifunctional as they target tumor cells via TAA binding, T-cells via CD3 targeting and FcγR bearing immune cells (NK cells, macrophages or dendritic cells) via FcγR binding.